Royal Bank of Canada »

Carmell Therapeutics Corp - US shares owned by Royal Bank of Canada

Quarter-by-quarter ownership of Carmell Therapeutics Corp - US (CTCX) shares owned by Royal Bank of Canada from 13F filings

Historical chart of Royal Bank of Canada investment in Carmell Therapeutics Corp - US

Tip: Access up to 7 years of quarterly data

All positions including Carmell Therapeutics Corp - US held by Royal Bank of Canada consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Carmell Therapeutics Corp - US by Royal Bank of Canada

Quarter filed Position value Share count Share price at filing
2024-09-30 $0 100 0.00
2024-03-31 $999 216 4.63
2023-12-31 $0 67 0.00

More positions owned by Royal Bank of Canada

Spdr S&p 500 Etf Tr Tr Unit (SPY)
Microsoft Corporation (MSFT)
Apple (AAPL)
NVIDIA Corporation (NVDA)
Amazon (AMZN)
Toronto Dominion Bk Ont Com New (TD)
Rbc Cad (RY)
Invesco Qqq Tr Unit Ser 1 (QQQ)
Ishares Tr Core S&p500 Etf (IVV)
Bk Nova Cad (BNS)
Ishares Tr Russell 2000 Etf (IWM)
Bank Of Montreal Cadcom (BMO)
JPMorgan Chase & Co. (JPM)
Enbridge (ENB)
Cibc Cad (CM)

View all positions for Royal Bank of Canada

Top funds holding Carmell Therapeutics Corp - US

Hubbell Strickland Wealth Management
Vanguard Group
Carnegie Mellon University
Geode Capital Management
BlackRock
Northern Trust
Warberg Asset Management
OZ Management
BlackRock
Bangor Savings Bank
Commonwealth Equity Services
St. Denis J. Villere & Co
Virtu Financial
Tower Research Capital
Morgan Stanley

View all funds holding Carmell Therapeutics Corp - US